Mitigating Pharmaceutical Production Risks Using Hot Water for Injection and Pure Steam

Wed, Feb 7, 2024 10:30 AM CET{LOCAL_TZ}

Event Overview:

Attend this webinar to gain valuable insights on how to conquer the significant obstacles faced by pharmaceutical and biotech companies during the production of hot water for injection and pure steam, all while staying true to sustainability goals. Learn about the improved Polaris™ 2.0 range, by Veolia Water Technologies, which includes the Multiple Effect Distiller (MED) for the production of hot water for injection and the Pure Steam Generator (PSG) for the production of pure steam.
These cutting-edge technologies have been designed to address the specific demands of the pharmaceutical industry, offering unparalleled reliability, efficiency, and quality. Not only do these solutions optimize production processes for hot water and pure steam, but also minimize environmental impact by reducing the consumption of industrial steam and energy.

Key Learning Objectives:
  • How Veolia Water Technologies supports pharmaceutical industries
  • The recent improvements made to the Polaris range
  • The importance of an improved maintainability of the units 
  • Meeting sustainability goals within the pharmaceutical industry
Agenda:
  • 10.30am CET - Introduction
  • 10.35am CET - Veolia Water Technologies capabilities in the Pharmaceutical Market
  • 10.45am CET - Pure fluids risk management with hot water for injection and pure steam
  • 11.05am CET - The Importance of a Service Partner
  • 11.15am CET - How to meet your pharmaceutical sustainability goals
  • 11.25am CET - Q&A



Featured Speakers


Valeria Anglani
Valeria Anglani
Polaris Product Manager
Veolia Water Technologies



Nicole Eranio
Nicole Eranio
Proposal Engineer Pharmaceutical
Veolia Water Technologies



Ranj Rihal
Ranj Rihal
Business Development Manager- Pharmaceutical
Veolia Water Technologies


Gareth Kearns
Gareth Kearns
European Solutions Manager- Pharma & Cosmetics
Veolia Water Technologies





For any technical questions please contact Jorge de la Bandera: JdelaBandera@mjhlifesciences.com